Convergence Partners AG
Overview
Convergence Partners AG is a Swiss venture capital firm that invests in founders building high-impact companies in healthcare sectors with large unmet needs, including digital health, medical devices, and diagnostics.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| b-rayZ AG | Jul 2022 | Series A | Lead |
| Prosoma | Jan 2025 | Series A | Co-investor |
| Clerkenwell Health | Oct 2022 | Seed | Co-investor |
| neotiv GmbH | Nov 2022 | Seed | Co-investor |
Key People
Daniel Koppelkamm
Founder & Managing Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Convergence Partners AG based?
Convergence Partners AG is headquartered in Baar, Switzerland.
When was Convergence Partners AG founded?
Convergence Partners AG was founded in 2018.
How many portfolio companies does Convergence Partners AG have?
Convergence Partners AG has 4 portfolio companies in Caplight's dataset.
What are some companies in Convergence Partners AG's portfolio?
Portfolio companies visible on Caplight include b-rayZ AG, Prosoma, Clerkenwell Health, neotiv GmbH.
What was Convergence Partners AG's most recent investment shown here?
Convergence Partners AG's most recent investment in this portfolio sample was in Prosoma in 2025.
What sectors does Convergence Partners AG focus on?
Convergence Partners AG focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Enterprise Software.
What company stages does Convergence Partners AG focus on?
Convergence Partners AG typically invests at the Early stage.